The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
Open Access
- 1 July 1978
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 62 (1), 54-60
- https://doi.org/10.1172/jci109113
Abstract
Activation of plasminogen through surface-mediated reactions is well recognized. In the presence of kaolin, purified Hageman factor (Factor XII) changed plasminogen to plasmin, as assayed upon a synthetic amide substrate and by fibrinolysis. Kinetic studies suggested an enzymatic action of Hageman factor upon its substrate, plasminogen. Hageman factor fragments, at a protein concentration equivalent to whole Hageman factor, activated plasminogen to a lesser extent. These protein preparations were not contaminated with other agents implicated in surface-mediated fibrinolysis. Diisopropyl fluorophosphate treatment of plasminogen did not inhibit its activation by Hageman factor. These studies indicate that Hageman factor has a hitherto unsuspected function, the direct activation of plasminogen.This publication has 21 references indexed in Scilit:
- The Hageman Factor Dependent Pathways of Coagulation, Fibrinolysis, and Kinin-GenerationSeminars in Thrombosis and Hemostasis, 1976
- FITZGERALD FACTOR (HIGH MOLECULAR-WEIGHT KININOGEN) CLOTTING ACTIVITY IN HUMAN-PLASMA IN HEALTH AND DISEASE IN VARIOUS ANIMAL PLASMAS1976
- An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH.Journal of Clinical Investigation, 1975
- Structural Changes Accompanying Enzymatic Activation of Human Hageman FactorJournal of Clinical Investigation, 1974
- Factor XII-induced fibrinolysis: Studies on the separation of prekallikrein, plasminogen proactivator, and factor XI in human plasmaThrombosis Research, 1974
- Partial Purification of Plasma Thromboplastin Antecedent (Factor XI) and its Activation by TrypsinJournal of Clinical Investigation, 1973
- THE FIBRINOLYTIC PATHWAY OF HUMAN PLASMAThe Journal of Experimental Medicine, 1972
- Studies on plasma thromboplastin antecedent (factor XI), PTA deficiency and inhibition of PTA by plasma: pharmacologic inhibitors and specific antiserum.1972
- Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactorsJournal of Clinical Investigation, 1969
- Activation of plasminogen by human plasma kallikreinBiochemical and Biophysical Research Communications, 1969